Camelot Portfolios’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-424
Closed -$87.7K 367
2025
Q4
$87.7K Buy
+424
New +$83.8K 0.05% 257
2024
Q3
Sell
-697
Closed -$102K 354
2024
Q2
$102K Buy
+697
New +$104K 0.06% 245
2022
Q3
Sell
-1,152
Closed -$205K 185
2022
Q2
$205K Buy
1,152
+2
+0.2% +$356 0.12% 190
2022
Q1
$204K Buy
+1,150
New +$196K 0.1% 215
2020
Q1
Sell
-1,871
Closed -$273K 229
2019
Q4
$273K Buy
1,871
+10
+0.5% +$1.36K 0.11% 183
2019
Q3
$241K Buy
1,861
+3
+0.2% +$395 0.11% 182
2019
Q2
$259K Buy
1,858
+115
+7% +$15.9K 0.11% 189
2019
Q1
$244K Sell
1,743
-310
-15% -$41.5K 0.1% 205
2018
Q4
$265K Buy
2,053
+537
+35% +$74.9K 0.12% 177
2018
Q3
$209K Buy
+1,516
New +$201K 0.09% 189
2016
Q1
Sell
-2,632
Closed -$270K 165
2015
Q4
$270K Buy
+2,632
New +$265K 0.17% 116
2015
Q1
Sell
-9,312
Closed -$974K 175
2014
Q4
$974K Buy
9,312
+180
+2% +$19K 0.56% 55
2014
Q3
$973K Sell
9,132
-1,256
-12% -$130K 0.57% 50
2014
Q2
$1.09M Buy
10,388
+976
+10% +$98.6K 0.7% 42
2014
Q1
$925K Sell
9,412
-14,152
-60% -$1.31M 0.62% 46
2013
Q4
$2.16M Sell
23,564
-1,509
-6% -$139K 1.39% 18
2013
Q3
$2.17M Sell
25,073
-1,155
-4% -$104K 1.59% 15
2013
Q2
$2.25M Buy
+26,228
New +$2.23M 1.71% 14

Other funds holding JNJ

Camelot Portfolios's JNJ Position: Q1 2026 in Review

Camelot Portfolios sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 424 shares — an estimated $87.7K sold.

Camelot Portfolios first reported a position in JNJ in Q2 2013 and held it in 18 quarters. The position peaked at $2.25M in Q2 2013. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Camelot Portfolios reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 424 Johnson & Johnson shares in Q1 2026, an estimated $87.7K.
  • Camelot Portfolios first reported a position in Johnson & Johnson in Q2 2013 and held it in 18 quarters.
  • Camelot Portfolios's Johnson & Johnson position peaked at $2.25M in Q2 2013.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.